High Tower Advisors, LLC Acadia Pharmaceuticals Inc Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
A detailed history of High Tower Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 10,417 shares of ACAD stock, worth $250,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,417
Previous 9,747
6.87%
Holding current value
$250,216
Previous $210,000
5.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ACAD
# of Institutions
370Shares Held
166MCall Options Held
1.49MPut Options Held
1M-
Baker Bros. Advisors LP New York, NY42.9MShares$1.03 Billion7.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA7.26MShares$174 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.14MShares$172 Million2.04% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.89B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...